Valentin Brodszky : Citation Profile


Are you Valentin Brodszky?

Budapesti Corvinus Egyetem

3

H index

1

i10 index

46

Citations

RESEARCH PRODUCTION:

25

Articles

2

Papers

RESEARCH ACTIVITY:

   9 years (2010 - 2019). See details.
   Cites by year: 5
   Journals where Valentin Brodszky has often published
   Relations with other researchers
   Recent citing documents: 2.    Total self citations: 9 (16.36 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pbr554
   Updated: 2024-04-18    RAS profile: 2023-03-16    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Baji, Petra (5)

Hermann, Zoltan (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Valentin Brodszky.

Is cited by:

Baji, Petra (8)

Brouwer, Werner (7)

Gulácsi, László (3)

Hermann, Zoltan (3)

Attema, Arthur (2)

oliva, juan (2)

van Exel, Job (1)

Weresa, Marzenna (1)

Pike, Jamison (1)

Barile, Sergio (1)

Kubak, Matus (1)

Cites to:

Gulácsi, László (21)

Péntek, Márta (20)

oliva, juan (13)

Baji, Petra (12)

Brouwer, Werner (10)

Boncz, Imre (8)

van Exel, Job (7)

Brazier, John (4)

Tsuchiya, Aki (4)

Parkin, David (3)

Devlin, Nancy (2)

Main data


Where Valentin Brodszky has published?


Journals with more than one article published# docs
The European Journal of Health Economics22

Recent works citing Valentin Brodszky (2024 and 2023)


YearTitle of citing document
2023.

Full description at Econpapers || Download paper

2023The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review. (2023). Drummond, Michael ; Nicod, Elena ; Meregaglia, Michela. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01541-y.

Full description at Econpapers || Download paper

Works by Valentin Brodszky:


YearTitleTypeCited
2015The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries? In: Society and Economy.
[Full Text][Citation analysis]
article1
2015The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries?.(2015) In: Corvinus Economics Working Papers (CEWP).
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1
paper
2015Trading between perceived risks and benefits related to biosimilar biological treatment in Crohn’s disease; discrete choice experiment among gastroenterologists In: Corvinus Economics Working Papers (CEWP).
[Full Text][Citation analysis]
paper0
2014Quality of Life and Costs in Parkinsons Disease: A Cross Sectional Study in Hungary In: PLOS ONE.
[Full Text][Citation analysis]
article3
2017Exploring the Relationship between Quality of Life (EQ-5D) and Clinical Measures in Adult Attention Deficit Hyperactivity Disorder (ADHD) In: Applied Research in Quality of Life.
[Full Text][Citation analysis]
article1
2010The disease burden of colorectal cancer in Hungary In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2014Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2014Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2014Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2014Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2014Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2014Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2014Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2014Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article4
2014Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2016Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article13
2016Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3
2019Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2019Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2019Validity and reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in a national survey in Hungary In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3
2019Patient and general population values for luminal and perianal fistulising Crohn’s disease health states In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2019Cost-of-illness studies in nine Central and Eastern European countries In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2019Subjective well-being in patients with pemphigus: a path analysis In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2019EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2019A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2019Is the trend of increasing use of patient-reported outcome measures in medical device studies the sign of shift towards value-based purchasing in Europe? In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2019Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 4 2024. Contact: CitEc Team